Metastatic Castration-Resistant Prostate Cancer
The Metastatic Castration-Resistant Prostate Cancer pipeline: 17 tracked drugs, 4 approved for this indication.
Coverage in progress. The assets here come from their companies' published pipelines. AssetMemo has not yet run its full census of every drug in development for Metastatic Castration-Resistant Prostate Cancer, so this list is not complete.
4 approved / phase 48 Phase 31 Phase 23 Phase 11 preclinical / unstaged
Compare the share prices of listed companies in Metastatic Castration-Resistant Prostate Cancer →
Market size not yet sourced. How markets are sized ↗